高敏肌钙蛋白T在识别疑似急性冠脉综合征极低危患者中的效能
这项前瞻性观察研究在美国15个急诊科纳入1600例疑似急性冠脉综合征患者,评估0小时和3小时高敏肌钙蛋白T(hsTnT)水平对30天不良心脏事件的识别价值。结果显示,单次hsTnT低于6 ng/L对急性心肌梗死的阴性预测值为99.4%;0和3小时hsTnT均≤19 ng/L的患者30天不良心脏事件阴性预测值为99.3%(95%CI 99.1-99.6)。
要点
- 单次hsTnT低于6 ng/L对急性心肌梗死阴性预测值达99.4%。
- 0和3小时hsTnT均≤19 ng/L可识别30天不良心脏事件风险低于1%的患者。
- 性别特异性切点下男女C统计量相似(女性0.952,男性0.962)。
核心结论
- 单次hsTnT低于6 ng/L与急性心肌梗死风险显著降低相关。
- 0和3小时hsTnT均≤19 ng/L可识别30天不良心脏事件风险低于1%的患者。
研究设计与样本
- 前瞻性观察研究,2011至2015年在美国15个急诊科进行。
- 纳入21岁及以上疑似急性冠脉综合征患者,最终分析1600例。
- 排除15例无肌钙蛋白T测量和320例缺失0或3小时样本者。
主要发现
- 在1301名健康志愿者中,hsTnT第99百分位上限为19 ng/L。
- 1600例患者中,基线单次hsTnT低于6 ng/L对急性心肌梗死阴性预测值为99.4%。
- 974例(77.1%)患者0和3小时hsTnT均≤19 ng/L,30天不良心脏事件阴性预测值为99.3%(95%CI 99.1-99.6)。
- 性别特异性切点下,女性C统计量0.952,男性0.962,对急性心肌梗死相似。
关键数值与推荐
- hsTnT第99百分位上限为19 ng/L(基于1301名健康美国志愿者)。
- 单次hsTnT低于6 ng/L对急性心肌梗死阴性预测值99.4%。
- 0和3小时hsTnT均≤19 ng/L对30天不良心脏事件阴性预测值99.3%(95%CI 99.1-99.6)。
临床怎么用
- 可使用0和3小时hsTnT均≤19 ng/L辅助识别30天不良心脏事件极低危患者。
- 单次hsTnT低于6 ng/L可提示急性心肌梗死风险显著降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Physicians need information on how to use the first available high-sensitivity troponin (hsTnT) assay in the United States to identify patients at very low risk for 30-day adverse cardiac events (ACE). OBJECTIVE: To determine whether a negative hsTnT assay at 0 and 3 hours following emergency department presentation could identify patients at less than 1% risk of a 30-day ACE. DESIGN, SETTING, AND PARTICIPANTS: A prospective, observational study at 15 emergency departments in the United States between 2011 and 2015 that included individuals 21 years and older, presenting to the emergency department with suspected acute coronary syndrome. Of 1690 eligible individuals, 15 (no cardiac troponin T measurement) and 320 (missing a 0-hour or 3-hour sample) were excluded from the analyses. EXPOSURES: Serial hsTnT measurements (fifth-generation Roche Elecsys hsTnT assay). MAIN OUTCOMES AND MEASURES: Serial blood samples from each patient were collected after emergency department presentation (once identified as a potential patient with acute coronary syndrome) and 3 hours, 6 to 9 hours, and 12 to 24 hours later. Adverse cardiac events were defined as myocardial infarction, urgent revascularization, or death. The upper reference level for the hsTnT assay, defined as the 99th percentile, was established as 19 ng/L in a separate healthy US cohort. Patients were considered ruled out for acute myocardial infarction if their hsTnT level at 0 hours and 3 hours was less than the upper reference level. Gold standard diagnoses were determined by a clinical end point committee. Evaluation of assay clinical performance for acute myocardial infarction rule-out was prespecified; the hypothesis regarding 30-day ACE was formulated after data collection. RESULTS: In 1301 healthy volunteers (50.4% women; median age, 48 years), the upper reference level was 19 ng/L. In 1600 patients with suspected acute coronary syndrome (48.4% women; median age, 55 years), a single hsTnTlevel less than 6 ng/L at baseline had a negative predictive value for AMI of 99.4%. In 974 patients (77.1%) with both 0-hour and 3-hour hsTnT levels of 19 ng/L or less, the negative predictive value for 30-day ACE was 99.3% (95% CI, 99.1-99.6). Using sex-specific cutpoints, C statistics for women (0.952) and men (0.962) were similar for acute myocardial infarction. CONCLUSIONS AND RELEVANCE: A single hsTnT level less than 6 ng/L was associated with a markedly decreased risk of AMI, while serial levels at 19 ng/L or less identified patients at less than 1% risk of 30-day ACE.
引用
- Peacock WF, Baumann BM, Bruton D, et al. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol. 2018. PMID: 29238804. doi:10.1001/jamacardio.2017.4625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。